103 related articles for article (PubMed ID: 25289642)
1. Cellular senescence in biliary pathology. Special emphasis on expression of a polycomb group protein EZH2 and a senescent marker p16INK4a in bile ductular tumors and lesions.
Sasaki M; Nakanuma Y
Histol Histopathol; 2015 Mar; 30(3):267-75. PubMed ID: 25289642
[TBL] [Abstract][Full Text] [Related]
2. Immunostaining for polycomb group protein EZH2 and senescent marker p16INK4a may be useful to differentiate cholangiolocellular carcinoma from ductular reaction and bile duct adenoma.
Sasaki M; Matsubara T; Kakuda Y; Sato Y; Nakanuma Y
Am J Surg Pathol; 2014 Mar; 38(3):364-9. PubMed ID: 24487593
[TBL] [Abstract][Full Text] [Related]
3. Novel immunohistochemical markers differentiate intrahepatic cholangiocarcinoma from benign bile duct lesions.
Bertram S; Padden J; Kälsch J; Ahrens M; Pott L; Canbay A; Weber F; Fingas C; Hoffmann AC; Vietor A; Schlaak JF; Eisenacher M; Reis H; Sitek B; Baba HA
J Clin Pathol; 2016 Jul; 69(7):619-26. PubMed ID: 26729014
[TBL] [Abstract][Full Text] [Related]
4. Over-expression of polycomb group protein EZH2 relates to decreased expression of p16 INK4a in cholangiocarcinogenesis in hepatolithiasis.
Sasaki M; Yamaguchi J; Itatsu K; Ikeda H; Nakanuma Y
J Pathol; 2008 Jun; 215(2):175-83. PubMed ID: 18393368
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of Bmi1 is closely associated with cellular senescence in small bile ducts in primary biliary cirrhosis.
Sasaki M; Ikeda H; Sato Y; Nakanuma Y
Am J Pathol; 2006 Sep; 169(3):831-45. PubMed ID: 16936260
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of enhancer of zeste homolog 2 and MUC1 may be related to malignant behaviour in intraductal papillary neoplasm of the bile duct.
Sasaki M; Matsubara T; Yoneda N; Nomoto K; Tsuneyama K; Sato Y; Nakanuma Y
Histopathology; 2013 Feb; 62(3):446-57. PubMed ID: 23163606
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of senescence-associated cell cycle regulators in the progression of biliary atresia: an immunohistochemical study.
Sasaki M; Kuo FY; Huang CC; Swanson PE; Chen CL; Chuang JH; Yeh MM
Histopathology; 2018 Jun; 72(7):1164-1171. PubMed ID: 29392752
[TBL] [Abstract][Full Text] [Related]
8. Autophagy may precede cellular senescence of bile ductular cells in ductular reaction in primary biliary cirrhosis.
Sasaki M; Miyakoshi M; Sato Y; Nakanuma Y
Dig Dis Sci; 2012 Mar; 57(3):660-6. PubMed ID: 21989821
[TBL] [Abstract][Full Text] [Related]
9. Bile ductular cells undergoing cellular senescence increase in chronic liver diseases along with fibrous progression.
Sasaki M; Ikeda H; Yamaguchi J; Miyakoshi M; Sato Y; Nakanuma Y
Am J Clin Pathol; 2010 Feb; 133(2):212-23. PubMed ID: 20093230
[TBL] [Abstract][Full Text] [Related]
10. Promoter methylation of INK4a/ARF as detected in bile-significance for the differential diagnosis in biliary disease.
Klump B; Hsieh CJ; Dette S; Holzmann K; Kiebetalich R; Jung M; Sinn U; Ortner M; Porschen R; Gregor M
Clin Cancer Res; 2003 May; 9(5):1773-8. PubMed ID: 12738733
[TBL] [Abstract][Full Text] [Related]
11. Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma cells by regulating cell cycle and apoptosis.
Nakagawa S; Okabe H; Sakamoto Y; Hayashi H; Hashimoto D; Yokoyama N; Sakamoto K; Kuroki H; Mima K; Nitta H; Imai K; Chikamoto A; Watanabe M; Beppu T; Baba H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S667-75. PubMed ID: 23887863
[TBL] [Abstract][Full Text] [Related]
12. Polycomb group protein Bmi1 is overexpressed and essential in anchorage-independent colony formation, cell proliferation and repression of cellular senescence in cholangiocarcinoma: tissue and culture studies.
Sasaki M; Yamaguchi J; Ikeda H; Itatsu K; Nakanuma Y
Hum Pathol; 2009 Dec; 40(12):1723-30. PubMed ID: 19695678
[TBL] [Abstract][Full Text] [Related]
13. H3K9me-enhanced DNA hypermethylation of the p16INK4a gene: an epigenetic signature for spontaneous transformation of rat mesenchymal stem cells.
Zheng Y; He L; Wan Y; Song J
Stem Cells Dev; 2013 Jan; 22(2):256-67. PubMed ID: 22873822
[TBL] [Abstract][Full Text] [Related]
14. Intrahepatic cholangiocarcinoma: new insights in pathology.
Sempoux C; Jibara G; Ward SC; Fan C; Qin L; Roayaie S; Fiel MI; Schwartz M; Thung SN
Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350
[TBL] [Abstract][Full Text] [Related]
15. A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: 'bile ductular carcinoma'.
Kozaka K; Sasaki M; Fujii T; Harada K; Zen Y; Sato Y; Sawada S; Minato H; Matsui O; Nakanuma Y
Histopathology; 2007 Sep; 51(3):390-400. PubMed ID: 17553067
[TBL] [Abstract][Full Text] [Related]
16. Bile duct adenoma and small-sized small duct type intrahepatic cholangiocarcinoma show distinct differences in genetic alterations, expression of IMP3 and EZH2 and stromal and inflammatory components.
Sasaki M; Sato Y; Nakanuma Y
Histopathology; 2023 Aug; 83(2):298-309. PubMed ID: 37140546
[TBL] [Abstract][Full Text] [Related]
17. Enhancer of zeste homologue 2 (EZH2) is a reliable immunohistochemical marker to differentiate malignant and benign hepatic tumors.
Hajósi-Kalcakosz S; Dezső K; Bugyik E; Bödör C; Paku S; Pávai Z; Halász J; Schlachter K; Schaff Z; Nagy P
Diagn Pathol; 2012 Jul; 7():86. PubMed ID: 22809481
[TBL] [Abstract][Full Text] [Related]
18. Contributions of hepatocytes and bile ductular cells in ductular reactions and remodeling of the biliary system after chronic liver injury.
Nagahama Y; Sone M; Chen X; Okada Y; Yamamoto M; Xin B; Matsuo Y; Komatsu M; Suzuki A; Enomoto K; Nishikawa Y
Am J Pathol; 2014 Nov; 184(11):3001-12. PubMed ID: 25193593
[TBL] [Abstract][Full Text] [Related]
19. Enhancer of zeste homolog 2 depletion induces cellular senescence via histone demethylation along the INK4/ARF locus.
Jie B; Weilong C; Ming C; Fei X; Xinghua L; Junhua C; Guobin W; Kaixiong T; Xiaoming S
Int J Biochem Cell Biol; 2015 Aug; 65():104-12. PubMed ID: 26004298
[TBL] [Abstract][Full Text] [Related]
20. Participation of bile ductular cells in the pathological progression of non-alcoholic fatty liver disease.
Chiba M; Sasaki M; Kitamura S; Ikeda H; Sato Y; Nakanuma Y
J Clin Pathol; 2011 Jul; 64(7):564-70. PubMed ID: 21486894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
